MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/16.01.26 Stock

Warrant

DE000MB9LVN9

Market Closed - Börse Stuttgart 02:19:11 2024-06-19 pm EDT
0.39 EUR -2.50% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/16.01.26
Current month-7.14%
1 month+8.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-19 0.39 -2.50%
24-06-18 0.4 +2.56%
24-06-17 0.39 0.00%
24-06-14 0.39 0.00%
24-06-13 0.39 +5.41%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 02:19 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB9LVN
ISINDE000MB9LVN9
Date issued 2023-08-08
Strike 100 $
Maturity 2026-01-16 (576 Days)
Parity 10 : 1
Emission price 1.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.17
Lowest since issue 0.34
Spread 0.04
Spread %9.30%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128 USD
Average target price
142.7 USD
Spread / Average Target
+11.48%
Consensus